Andy Scharenberg

Andy Scharenberg

Co-founder & Chief Executive Officer at Umoja Biopharma
Seattle, Washington, United States

Andy Scharenberg is Chief Executive Officer at Umoja Biopharma and Executive Partner at MPM BioImpact. He co-founded Generation Bio and Pregenen, and has served as Chief Scientific Officer at Casebia Therapeutics and Cellectis therapeutics. He has chaired scientific advisory boards at Alpine Immune Sciences and Generation Bio, and was a professor at the University of Washington and principal investigator at Seattle Children's Hospital and Research Institute.

  • Umoja Biopharma logo
    Umoja Biopharma Executive Officer, Director 2021–present, Co-founder & Chief Executive Officer 2019–present · current
  • MPM BioImpact Executive Partner 2019–present · current
  • Casebia Therapeutics Chief Scientific Officer 2017–2019 · past
  • Generation Bio Co-founder, Chair, Scientific Advisory Board 2017–2025 · past
  • Alpine Immune Sciences Chair, Scientific Advisory Board 2016–2024 · past
  • bluebird bio Scientific Advisory Board member 2014–2017 · past
  • Cellectis therapeutics Chief Scientific Officer 2011–2014 · past
  • Pregenen Co-founder and Member, Board of Directors 2009–2014 · past
  • Seattle Children's Hospital and Research Institute Principal Investigator 2000–2020 · past
  • University of Washington logo
    University of Washington Professor of Pediatrics and Immunology 2000–2020 · past

Education

  • University of North Carolina School of Medicine MD, Medicine · 1991–1993

Online